-
1
-
-
70449517400
-
Antiangiogenic therapies for high-grade glioma
-
10.1038/nrneurol.2009.159 19826401 10.1038/nrneurol.2009.159 1:CAS:528:DC%2BD1MXhtlKhtLbE
-
AD Norden J Drappatz PY Wen 2009 Antiangiogenic therapies for high-grade glioma Nat Rev Neurol 5 610 620 10.1038/nrneurol.2009.159 19826401 10.1038/nrneurol.2009.159 1:CAS:528:DC%2BD1MXhtlKhtLbE
-
(2009)
Nat Rev Neurol
, vol.5
, pp. 610-620
-
-
Norden, A.D.1
Drappatz, J.2
Wen, P.Y.3
-
2
-
-
70350461699
-
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
-
10.1200/JCO.2008.19.8721 19720927 10.1200/JCO.2008.19.8721 1:CAS:528:DC%2BD1MXhtlGgtbbM
-
HS Friedman MD Prados PY Wen T Mikkelsen D Schiff LE Abrey WK Yung N Paleologos MK Nicholas R Jensen J Vredenburgh J Huang M Zheng T Cloughesy 2009 Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 4733 4740 10.1200/JCO.2008.19.8721 19720927 10.1200/JCO.2008.19. 8721 1:CAS:528:DC%2BD1MXhtlGgtbbM
-
(2009)
J Clin Oncol
, vol.27
, pp. 4733-4740
-
-
Friedman, H.S.1
Prados, M.D.2
Wen, P.Y.3
Mikkelsen, T.4
Schiff, D.5
Abrey, L.E.6
Yung, W.K.7
Paleologos, N.8
Nicholas, M.K.9
Jensen, R.10
Vredenburgh, J.11
Huang, J.12
Zheng, M.13
Cloughesy, T.14
-
3
-
-
59949083263
-
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
-
10.1200/JCO.2008.16.3055 19114704 10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D
-
TN Kreisl L Kim K Moore P Duic C Royce I Stroud N Garren M Mackey JA Butman K Camphausen J Park PS Albert HA Fine 2009 Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 740 745 10.1200/JCO.2008.16.3055 19114704 10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D
-
(2009)
J Clin Oncol
, vol.27
, pp. 740-745
-
-
Kreisl, T.N.1
Kim, L.2
Moore, K.3
Duic, P.4
Royce, C.5
Stroud, I.6
Garren, N.7
MacKey, M.8
Butman, J.A.9
Camphausen, K.10
Park, J.11
Albert, P.S.12
Fine, H.A.13
-
4
-
-
67649092660
-
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
-
10.1215/15228517-2009-006 19332770 10.1215/15228517-2009-006 1:CAS:528:DC%2BD1MXhtlWht73P
-
EC Quant AD Norden J Drappatz A Muzikansky L Doherty D Lafrankie A Ciampa S Kesari PY Wen 2009 Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab Neuro Oncol 11 550 555 10.1215/15228517-2009-006 19332770 10.1215/15228517-2009-006 1:CAS:528:DC%2BD1MXhtlWht73P
-
(2009)
Neuro Oncol
, vol.11
, pp. 550-555
-
-
Quant, E.C.1
Norden, A.D.2
Drappatz, J.3
Muzikansky, A.4
Doherty, L.5
Lafrankie, D.6
Ciampa, A.7
Kesari, S.8
Wen, P.Y.9
-
5
-
-
34548141828
-
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
-
DOI 10.1093/jnci/djm086
-
FA Scappaticci JR Skillings SN Holden HP Gerber K Miller F Kabbinavar E Bergsland J Ngai E Holmgren J Wang H Hurwitz 2007 Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab J Natl Cancer Inst 99 1232 1239 10.1093/jnci/djm086 17686822 10.1093/jnci/djm086 (Pubitemid 47299901)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.16
, pp. 1232-1239
-
-
Scappaticci, F.A.1
Skillings, J.R.2
Holden, S.N.3
Gerber, H.-P.4
Miller, K.5
Kabbinavar, F.6
Bergsland, E.7
Ngai, J.8
Holmgren, E.9
Wang, J.10
Hurwitz, H.11
-
6
-
-
70350724766
-
Thrombotic events in patients with cancer receiving antiangiogenesis agents
-
10.1200/JCO.2009.22.3875 19704059 10.1200/JCO.2009.22.3875 1:CAS:528:DC%2BD1MXhtlKjtLvK
-
M Zangari LM Fink F Elice F Zhan DM Adcock GJ Tricot 2009 Thrombotic events in patients with cancer receiving antiangiogenesis agents J Clin Oncol 27 4865 4873 10.1200/JCO.2009.22.3875 19704059 10.1200/JCO.2009.22.3875 1:CAS:528:DC%2BD1MXhtlKjtLvK
-
(2009)
J Clin Oncol
, vol.27
, pp. 4865-4873
-
-
Zangari, M.1
Fink, L.M.2
Elice, F.3
Zhan, F.4
Adcock, D.M.5
Tricot, G.J.6
-
7
-
-
76649097338
-
Intracerebral and subarachnoid hemorrhage in patients with cancer
-
10.1212/WNL.0b013e3181cef837 20142616 10.1212/WNL.0b013e3181cef837 1:CAS:528:DC%2BC3cXhs1yhu7c%3D
-
BB Navi JS Reichman D Berlin AS Reiner KS Panageas AZ Segal LM DeAngelis 2010 Intracerebral and subarachnoid hemorrhage in patients with cancer Neurology 74 494 501 10.1212/WNL.0b013e3181cef837 20142616 10.1212/WNL.0b013e3181cef837 1:CAS:528:DC%2BC3cXhs1yhu7c%3D
-
(2010)
Neurology
, vol.74
, pp. 494-501
-
-
Navi, B.B.1
Reichman, J.S.2
Berlin, D.3
Reiner, A.S.4
Panageas, K.S.5
Segal, A.Z.6
Deangelis, L.M.7
-
8
-
-
46049098410
-
Ischemic stroke in patients with primary brain tumors
-
10.1212/01.wnl.0000314648.82924.6f 18541885 10.1212/01.wnl.0000314648. 82924.6f
-
TN Kreisl T Toothaker S Karimi LM DeAngelis 2008 Ischemic stroke in patients with primary brain tumors Neurology 70 2314 2320 10.1212/01.wnl. 0000314648.82924.6f 18541885 10.1212/01.wnl.0000314648.82924.6f
-
(2008)
Neurology
, vol.70
, pp. 2314-2320
-
-
Kreisl, T.N.1
Toothaker, T.2
Karimi, S.3
Deangelis, L.M.4
-
9
-
-
0026625163
-
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group
-
1379970
-
HP Adams Jr RF Woolson J Biller W Clarke 1992 Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group Haemostasis 22 99 103 1379970
-
(1992)
Haemostasis
, vol.22
, pp. 99-103
-
-
Adams Jr., H.P.1
Woolson, R.F.2
Biller, J.3
Clarke, W.4
-
10
-
-
33748376520
-
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
-
DOI 10.1158/1078-0432.CCR-06-0773
-
PY Wen WK Yung KR Lamborn PL Dahia Y Wang B Peng LE Abrey J Raizer TF Cloughesy K Fink M Gilbert S Chang L Junck D Schiff F Lieberman HA Fine M Mehta HI Robins LM DeAngelis MD Groves VK Puduvalli V Levin C Conrad EA Maher K Aldape M Hayes L Letvak MJ Egorin R Capdeville R Kaplan AJ Murgo C Stiles MD Prados 2006 Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08 Clin Cancer Res 12 4899 4907 10.1158/1078-0432 16914578 10.1158/1078-0432.CCR-06-0773 1:CAS:528: DC%2BD28XotFKgt70%3D (Pubitemid 44338577)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.16
, pp. 4899-4907
-
-
Wen, P.Y.1
Yung, W.K.A.2
Lamborn, K.R.3
Dahia, P.L.4
Wang, Y.5
Peng, B.6
Abrey, L.E.7
Raizer, J.8
Cloughesy, T.F.9
Fink, K.10
Gilbert, M.11
Chang, S.12
Junck, L.13
Schiff, D.14
Lieberman, F.15
Fine, H.A.16
Mehta, M.17
Robins, H.I.18
DeAngelis, L.M.19
Groves, M.D.20
Puduvalli, V.K.21
Levin, V.22
Conrad, C.23
Maher, E.A.24
Aldape, K.25
Hayes, M.26
Letvak, L.27
Egorin, M.J.28
Capdeville, R.29
Kaplan, R.30
Murgo, A.J.31
Stiles, C.32
Prados, M.D.33
more..
-
11
-
-
52949130889
-
What is the risk of intracranial bleeding during anti-VEGF therapy?
-
10.1215/15228517-2008-010 18539884 10.1215/15228517-2008-010
-
CP Carden JM Larkin MA Rosenthal 2008 What is the risk of intracranial bleeding during anti-VEGF therapy? Neuro Oncol 10 624 630 10.1215/15228517-2008- 010 18539884 10.1215/15228517-2008-010
-
(2008)
Neuro Oncol
, vol.10
, pp. 624-630
-
-
Carden, C.P.1
Larkin, J.M.2
Rosenthal, M.A.3
-
12
-
-
78049382933
-
Increased risk of serious hemorrhage with bevacizumab in cancer patients: A meta-analysis
-
10.1159/000314980 21051914 10.1159/000314980 1:CAS:528: DC%2BC3MXhtlaltA%3D%3D
-
S Hapani A Sher D Chu S Wu 2010 Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis Oncology 79 27 38 10.1159/000314980 21051914 10.1159/000314980 1:CAS:528:DC%2BC3MXhtlaltA%3D%3D
-
(2010)
Oncology
, vol.79
, pp. 27-38
-
-
Hapani, S.1
Sher, A.2
Chu, D.3
Wu, S.4
-
13
-
-
33744477354
-
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
-
DOI 10.1215/15228517-2005-010
-
MD Prados K Lamborn WK Yung K Jaeckle HI Robins M Mehta HA Fine PY Wen T Cloughesy S Chang MK Nicholas D Schiff H Greenberg L Junck K Fink K Hess J Kuhn 2006 A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study Neuro Oncol 8 189 193 10.1215/15228517-2005-010 16533878 10.1215/15228517-2005-010 1:CAS:528:DC%2BD28XksFSrur8%3D (Pubitemid 46542664)
-
(2006)
Neuro-Oncology
, vol.8
, Issue.2
, pp. 189-193
-
-
Prados, M.D.1
Lamborn, K.2
Yung, W.K.A.3
Jaeckle, K.4
Robins, H.I.5
Mehta, M.6
Fine, H.A.7
Wen, P.Y.8
Cloughesy, T.9
Chang, S.10
Nicholas, M.K.11
Schiff, D.12
Greenberg, H.13
Junck, L.14
Fink, K.15
Hess, K.16
Kuhn, J.17
-
14
-
-
14944353655
-
Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American brain tumor consortium study
-
DOI 10.1200/JCO.2004.09.096
-
VK Puduvalli WK Yung KR Hess JG Kuhn MD Groves VA Levin J Zwiebel SM Chang TF Cloughesy L Junck P Wen F Lieberman CA Conrad MR Gilbert CA Meyers V Liu MP Mehta MK Nicholas M Prados 2004 Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study J Clin Oncol 22 4282 4289 10.1200/JCO.2004.09.096 15514370 10.1200/JCO.2004.09.096 1:CAS:528:DC%2BD2cXhtVKju7fM (Pubitemid 41185149)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.21
, pp. 4282-4289
-
-
Puduvalli, V.K.1
Yung, W.K.A.2
Hess, K.R.3
Kuhn, J.G.4
Groves, M.D.5
Levin, V.A.6
Zwiebel, J.7
Chang, S.M.8
Cloughesy, T.F.9
Junck, L.10
Wen, P.11
Lieberman, F.12
Conrad, C.A.13
Gilbert, M.R.14
Meyers, C.A.15
Liu, V.16
Mehta, M.P.17
Nicholas, M.K.18
Prados, M.19
-
15
-
-
33747058029
-
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study
-
DOI 10.1200/JCO.2006.06.2323
-
TF Cloughesy PY Wen HI Robins SM Chang MD Groves KL Fink L Junck D Schiff L Abrey MR Gilbert F Lieberman J Kuhn LM DeAngelis M Mehta JJ Raizer WK Yung K Aldape J Wright KR Lamborn MD Prados 2006 Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study J Clin Oncol 24 3651 3656 10.1200/JCO.2006.06.2323 16877733 10.1200/JCO.2006.06.2323 1:CAS:528:DC%2BD28XovVSjsbo%3D (Pubitemid 46630540)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.22
, pp. 3651-3656
-
-
Cloughesy, T.F.1
Wen, P.Y.2
Robins, H.I.3
Chang, S.M.4
Groves, M.D.5
Fink, K.L.6
Junck, L.7
Schiff, D.8
Abrey, L.9
Gilbert, M.R.10
Lieberman, F.11
Kuhn, J.12
DeAngelis, L.M.13
Mehta, M.14
Raizer, J.J.15
Yung, W.K.A.16
Aldape, K.17
Wright, J.18
Lamborn, K.R.19
Prados, M.D.20
more..
-
16
-
-
57349153494
-
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: A North American Brain Tumor Consortium (NABTC01-05)
-
10.1007/s11060-008-9693-3 18797818 10.1007/s11060-008-9693-3 1:CAS:528:DC%2BD1MXjvFeiuw%3D%3D
-
N Butowski SM Chang L Junck LM DeAngelis L Abrey K Fink T Cloughesy KR Lamborn AM Salazar MD Prados 2009 A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) J Neurooncol 91 175 182 10.1007/s11060-008-9693-3 18797818 10.1007/s11060-008-9693-3 1:CAS:528:DC%2BD1MXjvFeiuw%3D%3D
-
(2009)
J Neurooncol
, vol.91
, pp. 175-182
-
-
Butowski, N.1
Chang, S.M.2
Junck, L.3
Deangelis, L.M.4
Abrey, L.5
Fink, K.6
Cloughesy, T.7
Lamborn, K.R.8
Salazar, A.M.9
Prados, M.D.10
-
17
-
-
75749122223
-
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
-
10.1093/neuonc/nop015 20150372 1:CAS:528:DC%2BC3cXjvFCnt7Y%3D
-
JJ Raizer LE Abrey AB Lassman SM Chang KR Lamborn JG Kuhn WK Yung MR Gilbert KA Aldape PY Wen HA Fine M Mehta LM Deangelis F Lieberman TF Cloughesy HI Robins J Dancey MD Prados 2010 A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy Neuro Oncol 12 95 103 10.1093/neuonc/nop015 20150372 1:CAS:528:DC%2BC3cXjvFCnt7Y%3D
-
(2010)
Neuro Oncol
, vol.12
, pp. 95-103
-
-
Raizer, J.J.1
Abrey, L.E.2
Lassman, A.B.3
Chang, S.M.4
Lamborn, K.R.5
Kuhn, J.G.6
Yung, W.K.7
Gilbert, M.R.8
Aldape, K.A.9
Wen, P.Y.10
Fine, H.A.11
Mehta, M.12
Deangelis, L.M.13
Lieberman, F.14
Cloughesy, T.F.15
Robins, H.I.16
Dancey, J.17
Prados, M.D.18
-
18
-
-
21044431575
-
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
-
DOI 10.1007/s10637-005-1444-0
-
SM Chang P Wen T Cloughesy H Greenberg D Schiff C Conrad K Fink HI Robins L De Angelis J Raizer K Hess K Aldape KR Lamborn J Kuhn J Dancey MD Prados 2005 Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme Invest New Drugs 23 357 361 10.1007/s10637-005-1444-0 16012795 10.1007/s10637-005-1444-0 1:CAS:528:DC%2BD2MXmtVymtLY%3D (Pubitemid 40980358)
-
(2005)
Investigational New Drugs
, vol.23
, Issue.4
, pp. 357-361
-
-
Chang, S.M.1
Wen, P.2
Cloughesy, T.3
Greenberg, H.4
Schiff, D.5
Conrad, C.6
Fink, K.7
Robins, H.I.8
De Angelis, L.9
Raizer, J.10
Hess, K.11
Aldape, K.12
Lamborn, K.R.13
Kuhn, J.14
Dancey, J.15
Prados, M.D.16
-
19
-
-
79959956310
-
A phase I/II trial of the histone deacetylase inhibitor, romidepsin, for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
-
doi: 10.1093/neuonc/nor017
-
Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA (2011) A phase I/II trial of the histone deacetylase inhibitor, romidepsin, for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol. doi: 10.1093/neuonc/nor017
-
(2011)
Neuro Oncol.
-
-
Iwamoto, F.M.1
Lamborn, K.R.2
Kuhn, J.G.3
Wen, P.Y.4
Yung, W.K.5
Gilbert, M.R.6
Chang, S.M.7
Lieberman, F.S.8
Prados, M.D.9
Fine, H.A.10
-
20
-
-
33846857559
-
Heart disease and stroke statistics - 2007 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
DOI 10.1161/CIRCULATIONAHA.106.179918, PII 0000301720070206000024
-
W Rosamond K Flegal G Friday K Furie A Go K Greenlund N Haase M Ho V Howard B Kissela S Kittner D Lloyd-Jones M McDermott J Meigs C Moy G Nichol CJ O'Donnell V Roger J Rumsfeld P Sorlie J Steinberger T Thom S Wasserthiel-Smoller Y Hong 2007 Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 e69 e171 10.1161/CIRCULATIONAHA.106.179918 17194875 10.1161/CIRCULATIONAHA.106.179918 (Pubitemid 46226160)
-
(2007)
Circulation
, vol.115
, Issue.5
-
-
Rosamond, W.1
Flegal, K.2
Friday, G.3
Furie, K.4
Go, A.5
Greenlund, K.6
Haase, N.7
Ho, M.8
Howard, V.9
Kissela, B.10
Kittner, S.11
Lloyd-Jones, D.12
McDermott, M.13
Meigs, J.14
Moy, C.15
Nichol, G.16
O'Donnell, C.J.17
Roger, V.18
Rumsfeld, J.19
Sorlie, P.20
Steinberger, J.21
Thom, T.22
Wasserthiel-Smoller, S.23
Hong, Y.24
more..
-
21
-
-
78149492402
-
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
-
10.1093/neuonc/noq025 20200024 10.1093/neuonc/noq025 1:CAS:528: DC%2BC3cXpvFSlt70%3D
-
FM Iwamoto KR Lamborn HI Robins MP Mehta SM Chang NA Butowski LM Deangelis LE Abrey WT Zhang MD Prados HA Fine 2010 Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02) Neuro Oncol 12 855 861 10.1093/neuonc/noq025 20200024 10.1093/neuonc/noq025 1:CAS:528:DC%2BC3cXpvFSlt70%3D
-
(2010)
Neuro Oncol
, vol.12
, pp. 855-861
-
-
Iwamoto, F.M.1
Lamborn, K.R.2
Robins, H.I.3
Mehta, M.P.4
Chang, S.M.5
Butowski, N.A.6
Deangelis, L.M.7
Abrey, L.E.8
Zhang, W.T.9
Prados, M.D.10
Fine, H.A.11
-
22
-
-
79951984402
-
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme
-
10.1200/JCO.2010.30.2729 21135282 10.1200/JCO.2010.30.2729 1:CAS:528:DC%2BC3MXhvVahtb0%3D
-
A Lai A Tran PL Nghiemphu WB Pope OE Solis M Selch E Filka WH Yong PS Mischel LM Liau S Phuphanich K Black S Peak RM Green CE Spier T Kolevska J Polikoff L Fehrenbacher R Elashoff T Cloughesy 2011 Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme J Clin Oncol 29 142 148 10.1200/JCO.2010.30.2729 21135282 10.1200/JCO.2010.30.2729 1:CAS:528: DC%2BC3MXhvVahtb0%3D
-
(2011)
J Clin Oncol
, vol.29
, pp. 142-148
-
-
Lai, A.1
Tran, A.2
Nghiemphu, P.L.3
Pope, W.B.4
Solis, O.E.5
Selch, M.6
Filka, E.7
Yong, W.H.8
Mischel, P.S.9
Liau, L.M.10
Phuphanich, S.11
Black, K.12
Peak, S.13
Green, R.M.14
Spier, C.E.15
Kolevska, T.16
Polikoff, J.17
Fehrenbacher, L.18
Elashoff, R.19
Cloughesy, T.20
more..
-
23
-
-
77954382544
-
Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients
-
10.1007/s11060-009-0098-8 20035366 10.1007/s11060-009-0098-8 1:CAS:528:DC%2BC3cXotlCnt78%3D
-
J Rieger O Bahr K Muller K Franz J Steinbach E Hattingen 2010 Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients J Neurooncol 99 49 56 10.1007/s11060-009-0098-8 20035366 10.1007/s11060-009-0098-8 1:CAS:528:DC%2BC3cXotlCnt78%3D
-
(2010)
J Neurooncol
, vol.99
, pp. 49-56
-
-
Rieger, J.1
Bahr, O.2
Muller, K.3
Franz, K.4
Steinbach, J.5
Hattingen, E.6
-
24
-
-
77949911509
-
Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab
-
10.1200/JCO.2009.25.0233 19933906 10.1200/JCO.2009.25.0233
-
ER Gerstner MP Frosch TT Batchelor 2010 Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab J Clin Oncol 28 e91 e93 10.1200/JCO.2009.25.0233 19933906 10.1200/JCO.2009.25.0233
-
(2010)
J Clin Oncol
, vol.28
-
-
Gerstner, E.R.1
Frosch, M.P.2
Batchelor, T.T.3
-
25
-
-
1542268250
-
Nonconvulsive Status Epilepticus in Patients with Cancer: Imaging Abnormalities
-
DOI 10.1001/archneur.61.3.362
-
A Hormigo B Liberato E Lis LM DeAngelis 2004 Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities Arch Neurol 61 362 365 10.1001/archneur.61.3.362 15023812 10.1001/archneur.61.3.362 (Pubitemid 38327353)
-
(2004)
Archives of Neurology
, vol.61
, Issue.3
, pp. 362-365
-
-
Hormigo, A.1
Liberato, B.2
Lis, E.3
DeAngelis, L.M.4
-
26
-
-
34250365240
-
Mechanisms of adverse effects of anti-VEGF therapy for cancer
-
DOI 10.1038/sj.bjc.6603813, PII 6603813
-
T Kamba DM McDonald 2007 Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 1788 1795 10.1038/sj.bjc.6603813 17519900 10.1038/sj.bjc.6603813 1:CAS:528:DC%2BD2sXmtlyqur4%3D (Pubitemid 46912024)
-
(2007)
British Journal of Cancer
, vol.96
, Issue.12
, pp. 1788-1795
-
-
Kamba, T.1
McDonald, D.M.2
|